Reporting of new Aggregate Case and Death Count data was discontinued May 11, 2023, with the expiration of the COVID-19 public health emergency declaration. This dataset will receive a final update on June 1, 2023, to reconcile historical data through May 10, 2023, and will remain publicly available.
Aggregate Data Collection Process Since the start of the COVID-19 pandemic, data have been gathered through a robust process with the following steps:
Methodology Changes Several differences exist between the current, weekly-updated dataset and the archived version:
Confirmed and Probable Counts In this dataset, counts by jurisdiction are not displayed by confirmed or probable status. Instead, confirmed and probable cases and deaths are included in the Total Cases and Total Deaths columns, when available. Not all jurisdictions report probable cases and deaths to CDC.* Confirmed and probable case definition criteria are described here:
Council of State and Territorial Epidemiologists (ymaws.com).
Deaths CDC reports death data on other sections of the website: CDC COVID Data Tracker: Home, CDC COVID Data Tracker: Cases, Deaths, and Testing, and NCHS Provisional Death Counts. Information presented on the COVID Data Tracker pages is based on the same source (to
https://github.com/nytimes/covid-19-data/blob/master/LICENSEhttps://github.com/nytimes/covid-19-data/blob/master/LICENSE
The New York Times is releasing a series of data files with cumulative counts of coronavirus cases in the United States, at the state and county level, over time. We are compiling this time series data from state and local governments and health departments in an attempt to provide a complete record of the ongoing outbreak.
Since the first reported coronavirus case in Washington State on Jan. 21, 2020, The Times has tracked cases of coronavirus in real time as they were identified after testing. Because of the widespread shortage of testing, however, the data is necessarily limited in the picture it presents of the outbreak.
We have used this data to power our maps and reporting tracking the outbreak, and it is now being made available to the public in response to requests from researchers, scientists and government officials who would like access to the data to better understand the outbreak.
The data begins with the first reported coronavirus case in Washington State on Jan. 21, 2020. We will publish regular updates to the data in this repository.
Notice of data discontinuation: Since the start of the pandemic, AP has reported case and death counts from data provided by Johns Hopkins University. Johns Hopkins University has announced that they will stop their daily data collection efforts after March 10. As Johns Hopkins stops providing data, the AP will also stop collecting daily numbers for COVID cases and deaths. The HHS and CDC now collect and visualize key metrics for the pandemic. AP advises using those resources when reporting on the pandemic going forward.
April 9, 2020
April 20, 2020
April 29, 2020
September 1st, 2020
February 12, 2021
new_deaths
column.February 16, 2021
The AP is using data collected by the Johns Hopkins University Center for Systems Science and Engineering as our source for outbreak caseloads and death counts for the United States and globally.
The Hopkins data is available at the county level in the United States. The AP has paired this data with population figures and county rural/urban designations, and has calculated caseload and death rates per 100,000 people. Be aware that caseloads may reflect the availability of tests -- and the ability to turn around test results quickly -- rather than actual disease spread or true infection rates.
This data is from the Hopkins dashboard that is updated regularly throughout the day. Like all organizations dealing with data, Hopkins is constantly refining and cleaning up their feed, so there may be brief moments where data does not appear correctly. At this link, you’ll find the Hopkins daily data reports, and a clean version of their feed.
The AP is updating this dataset hourly at 45 minutes past the hour.
To learn more about AP's data journalism capabilities for publishers, corporations and financial institutions, go here or email kromano@ap.org.
Use AP's queries to filter the data or to join to other datasets we've made available to help cover the coronavirus pandemic
Filter cases by state here
Rank states by their status as current hotspots. Calculates the 7-day rolling average of new cases per capita in each state: https://data.world/associatedpress/johns-hopkins-coronavirus-case-tracker/workspace/query?queryid=481e82a4-1b2f-41c2-9ea1-d91aa4b3b1ac
Find recent hotspots within your state by running a query to calculate the 7-day rolling average of new cases by capita in each county: https://data.world/associatedpress/johns-hopkins-coronavirus-case-tracker/workspace/query?queryid=b566f1db-3231-40fe-8099-311909b7b687&showTemplatePreview=true
Join county-level case data to an earlier dataset released by AP on local hospital capacity here. To find out more about the hospital capacity dataset, see the full details.
Pull the 100 counties with the highest per-capita confirmed cases here
Rank all the counties by the highest per-capita rate of new cases in the past 7 days here. Be aware that because this ranks per-capita caseloads, very small counties may rise to the very top, so take into account raw caseload figures as well.
The AP has designed an interactive map to track COVID-19 cases reported by Johns Hopkins.
@(https://datawrapper.dwcdn.net/nRyaf/15/)
<iframe title="USA counties (2018) choropleth map Mapping COVID-19 cases by county" aria-describedby="" id="datawrapper-chart-nRyaf" src="https://datawrapper.dwcdn.net/nRyaf/10/" scrolling="no" frameborder="0" style="width: 0; min-width: 100% !important;" height="400"></iframe><script type="text/javascript">(function() {'use strict';window.addEventListener('message', function(event) {if (typeof event.data['datawrapper-height'] !== 'undefined') {for (var chartId in event.data['datawrapper-height']) {var iframe = document.getElementById('datawrapper-chart-' + chartId) || document.querySelector("iframe[src*='" + chartId + "']");if (!iframe) {continue;}iframe.style.height = event.data['datawrapper-height'][chartId] + 'px';}}});})();</script>
Johns Hopkins timeseries data - Johns Hopkins pulls data regularly to update their dashboard. Once a day, around 8pm EDT, Johns Hopkins adds the counts for all areas they cover to the timeseries file. These counts are snapshots of the latest cumulative counts provided by the source on that day. This can lead to inconsistencies if a source updates their historical data for accuracy, either increasing or decreasing the latest cumulative count. - Johns Hopkins periodically edits their historical timeseries data for accuracy. They provide a file documenting all errors in their timeseries files that they have identified and fixed here
This data should be credited to Johns Hopkins University COVID-19 tracking project
https://www.usa.gov/government-workshttps://www.usa.gov/government-works
Note: Reporting of new COVID-19 Case Surveillance data will be discontinued July 1, 2024, to align with the process of removing SARS-CoV-2 infections (COVID-19 cases) from the list of nationally notifiable diseases. Although these data will continue to be publicly available, the dataset will no longer be updated.
Authorizations to collect certain public health data expired at the end of the U.S. public health emergency declaration on May 11, 2023. The following jurisdictions discontinued COVID-19 case notifications to CDC: Iowa (11/8/21), Kansas (5/12/23), Kentucky (1/1/24), Louisiana (10/31/23), New Hampshire (5/23/23), and Oklahoma (5/2/23). Please note that these jurisdictions will not routinely send new case data after the dates indicated. As of 7/13/23, case notifications from Oregon will only include pediatric cases resulting in death.
This case surveillance public use dataset has 12 elements for all COVID-19 cases shared with CDC and includes demographics, any exposure history, disease severity indicators and outcomes, presence of any underlying medical conditions and risk behaviors, and no geographic data.
The COVID-19 case surveillance database includes individual-level data reported to U.S. states and autonomous reporting entities, including New York City and the District of Columbia (D.C.), as well as U.S. territories and affiliates. On April 5, 2020, COVID-19 was added to the Nationally Notifiable Condition List and classified as “immediately notifiable, urgent (within 24 hours)” by a Council of State and Territorial Epidemiologists (CSTE) Interim Position Statement (Interim-20-ID-01). CSTE updated the position statement on August 5, 2020, to clarify the interpretation of antigen detection tests and serologic test results within the case classification (Interim-20-ID-02). The statement also recommended that all states and territories enact laws to make COVID-19 reportable in their jurisdiction, and that jurisdictions conducting surveillance should submit case notifications to CDC. COVID-19 case surveillance data are collected by jurisdictions and reported voluntarily to CDC.
For more information:
NNDSS Supports the COVID-19 Response | CDC.
The deidentified data in the “COVID-19 Case Surveillance Public Use Data” include demographic characteristics, any exposure history, disease severity indicators and outcomes, clinical data, laboratory diagnostic test results, and presence of any underlying medical conditions and risk behaviors. All data elements can be found on the COVID-19 case report form located at www.cdc.gov/coronavirus/2019-ncov/downloads/pui-form.pdf.
COVID-19 case reports have been routinely submitted using nationally standardized case reporting forms. On April 5, 2020, CSTE released an Interim Position Statement with national surveillance case definitions for COVID-19 included. Current versions of these case definitions are available here: https://ndc.services.cdc.gov/case-definitions/coronavirus-disease-2019-2021/.
All cases reported on or after were requested to be shared by public health departments to CDC using the standardized case definitions for laboratory-confirmed or probable cases. On May 5, 2020, the standardized case reporting form was revised. Case reporting using this new form is ongoing among U.S. states and territories.
To learn more about the limitations in using case surveillance data, visit FAQ: COVID-19 Data and Surveillance.
CDC’s Case Surveillance Section routinely performs data quality assurance procedures (i.e., ongoing corrections and logic checks to address data errors). To date, the following data cleaning steps have been implemented:
To prevent release of data that could be used to identify people, data cells are suppressed for low frequency (<5) records and indirect identifiers (e.g., date of first positive specimen). Suppression includes rare combinations of demographic characteristics (sex, age group, race/ethnicity). Suppressed values are re-coded to the NA answer option; records with data suppression are never removed.
For questions, please contact Ask SRRG (eocevent394@cdc.gov).
COVID-19 data are available to the public as summary or aggregate count files, including total counts of cases and deaths by state and by county. These
U.S. Government Workshttps://www.usa.gov/government-works
License information was derived automatically
Note: DPH is updating and streamlining the COVID-19 cases, deaths, and testing data. As of 6/27/2022, the data will be published in four tables instead of twelve.
The COVID-19 Cases, Deaths, and Tests by Day dataset contains cases and test data by date of sample submission. The death data are by date of death. This dataset is updated daily and contains information back to the beginning of the pandemic. The data can be found at https://data.ct.gov/Health-and-Human-Services/COVID-19-Cases-Deaths-and-Tests-by-Day/g9vi-2ahj.
The COVID-19 State Metrics dataset contains over 93 columns of data. This dataset is updated daily and currently contains information starting June 21, 2022 to the present. The data can be found at https://data.ct.gov/Health-and-Human-Services/COVID-19-State-Level-Data/qmgw-5kp6 .
The COVID-19 County Metrics dataset contains 25 columns of data. This dataset is updated daily and currently contains information starting June 16, 2022 to the present. The data can be found at https://data.ct.gov/Health-and-Human-Services/COVID-19-County-Level-Data/ujiq-dy22 .
The COVID-19 Town Metrics dataset contains 16 columns of data. This dataset is updated daily and currently contains information starting June 16, 2022 to the present. The data can be found at https://data.ct.gov/Health-and-Human-Services/COVID-19-Town-Level-Data/icxw-cada . To protect confidentiality, if a town has fewer than 5 cases or positive NAAT tests over the past 7 days, those data will be suppressed.
This dataset includes a count and rate per 100,000 population for COVID-19 cases, a count of COVID-19 molecular diagnostic tests, and a percent positivity rate for tests among people living in community settings for the previous two-week period. Dates are based on date of specimen collection (cases and positivity).
A person is considered a new case only upon their first COVID-19 testing result because a case is defined as an instance or bout of illness. If they are tested again subsequently and are still positive, it still counts toward the test positivity metric but they are not considered another case.
Percent positivity is calculated as the number of positive tests among community residents conducted during the 14 days divided by the total number of positive and negative tests among community residents during the same period. If someone was tested more than once during that 14 day period, then those multiple test results (regardless of whether they were positive or negative) are included in the calculation.
These case and test counts do not include cases or tests among people residing in congregate settings, such as nursing homes, assisted living facilities, or correctional facilities.
These data are updated weekly and reflect the previous two full Sunday-Saturday (MMWR) weeks (https://wwwn.cdc.gov/nndss/document/MMWR_week_overview.pdf).
DPH note about change from 7-day to 14-day metrics: Prior to 10/15/2020, these metrics were calculated using a 7-day average rather than a 14-day average. The 7-day metrics are no longer being updated as of 10/15/2020 but the archived dataset can be accessed here: https://data.ct.gov/Health-and-Human-Services/COVID-19-case-rate-per-100-000-population-and-perc/s22x-83rd
As you know, we are learning more about COVID-19 all the time, including the best ways to measure COVID-19 activity in our communities. CT DPH has decided to shift to 14-day rates because these are more stable, particularly at the town level, as compared to 7-day rates. In addition, since the school indicators were initially published by DPH last summer, CDC has recommended 14-day rates and other states (e.g., Massachusetts) have started to implement 14-day metrics for monitoring COVID transmission as well.
With respect to geography, we also have learned that many people are looking at the town-level data to inform decision making, despite emphasis on the county-level metrics in the published addenda. This is understandable as there has been variation within counties in COVID-19 activity (for example, rates that are higher in one town than in most other towns in the county).
Additional notes: As of 11/5/2020, CT DPH has added antigen testing for SARS-CoV-2 to reported test counts in this dataset. The tests included in this dataset include both molecular and antigen datasets. Molecular tests reported include polymerase chain reaction (PCR) and nucleic acid amplicfication (NAAT) tests.
The population data used to calculate rates is based on the CT DPH population statistics for 2019, which is available online here: https://portal.ct.gov/DPH/Health-Information-Systems--Reporting/Population/Population-Statistics. Prior to 5/10/2021, the population estimates from 2018 were used.
Data suppression is applied when the rate is <5 cases per 100,000 or if there are <5 cases within the town. Information on why data suppression rules are applied can be found online here: https://www.cdc.gov/cancer/uscs/technical_notes/stat_methods/suppression.htm
Open Data Commons Attribution License (ODC-By) v1.0https://www.opendatacommons.org/licenses/by/1.0/
License information was derived automatically
After May 3, 2024, this dataset and webpage will no longer be updated because hospitals are no longer required to report data on COVID-19 hospital admissions, and hospital capacity and occupancy data, to HHS through CDC’s National Healthcare Safety Network. Data voluntarily reported to NHSN after May 1, 2024, will be available starting May 10, 2024, at COVID Data Tracker Hospitalizations.
This time series dataset includes viral COVID-19 laboratory test [Polymerase chain reaction (PCR)] results from over 1,000 U.S. laboratories and testing locations including commercial and reference laboratories, public health laboratories, hospital laboratories, and other testing locations. Data are reported to state and jurisdictional health departments in accordance with applicable state or local law and in accordance with the Coronavirus Aid, Relief, and Economic Security (CARES) Act (CARES Act Section 18115).
Data are provisional and subject to change.
Data presented here is representative of diagnostic specimens being tested - not individual people - and excludes serology tests where possible. Data presented might not represent the most current counts for the most recent 3 days due to the time it takes to report testing information. The data may also not include results from all potential testing sites within the jurisdiction (e.g., non-laboratory or point of care test sites) and therefore reflect the majority, but not all, of COVID-19 testing being conducted in the United States.
Sources: CDC COVID-19 Electronic Laboratory Reporting (CELR), Commercial Laboratories, State Public Health Labs, In-House Hospital Labs
Data for each state is sourced from either data submitted directly by the state health department via COVID-19 electronic laboratory reporting (CELR), or a combination of commercial labs, public health labs, and in-house hospital labs. Data is taken from CELR for states that either submit line level data or submit aggregate counts which do not include serology tests.
DPH note about change from 7-day to 14-day metrics: As of 10/15/2020, this dataset is no longer being updated. Starting on 10/15/2020, these metrics will be calculated using a 14-day average rather than a 7-day average. The new dataset using 14-day averages can be accessed here: https://data.ct.gov/Health-and-Human-Services/COVID-19-case-rate-per-100-000-population-and-perc/hree-nys2 As you know, we are learning more about COVID-19 all the time, including the best ways to measure COVID-19 activity in our communities. CT DPH has decided to shift to 14-day rates because these are more stable, particularly at the town level, as compared to 7-day rates. In addition, since the school indicators were initially published by DPH last summer, CDC has recommended 14-day rates and other states (e.g., Massachusetts) have started to implement 14-day metrics for monitoring COVID transmission as well. With respect to geography, we also have learned that many people are looking at the town-level data to inform decision making, despite emphasis on the county-level metrics in the published addenda. This is understandable as there has been variation within counties in COVID-19 activity (for example, rates that are higher in one town than in most other towns in the county). This dataset includes a weekly count and weekly rate per 100,000 population for COVID-19 cases, a weekly count of COVID-19 PCR diagnostic tests, and a weekly percent positivity rate for tests among people living in community settings. Dates are based on date of specimen collection (cases and positivity). A person is considered a new case only upon their first COVID-19 testing result because a case is defined as an instance or bout of illness. If they are tested again subsequently and are still positive, it still counts toward the test positivity metric but they are not considered another case. These case and test counts do not include cases or tests among people residing in congregate settings, such as nursing homes, assisted living facilities, or correctional facilities. These data are updated weekly; the previous week period for each dataset is the previous Sunday-Saturday, known as an MMWR week (https://wwwn.cdc.gov/nndss/document/MMWR_week_overview.pdf). The date listed is the date the dataset was last updated and corresponds to a reporting period of the previous MMWR week. For instance, the data for 8/20/2020 corresponds to a reporting period of 8/9/2020-8/15/2020. Notes: 9/25/2020: Data for Mansfield and Middletown for the week of Sept 13-19 were unavailable at the time of reporting due to delays in lab reporting.
This dataset contains information on antibody testing for COVID-19: the number of people who received a test, the number of people with positive results, the percentage of people tested who tested positive, and the rate of testing per 100,000 people, stratified by sex. These data can also be accessed here: https://github.com/nychealth/coronavirus-data/blob/master/totals/antibody-by-sex.csv Exposure to COVID-19 can be detected by measuring antibodies to the disease in a person’s blood, which can indicate that a person may have had an immune response to the virus. Antibodies are proteins produced by the body’s immune system that can be found in the blood. People can test positive for antibodies after they have been exposed, sometimes when they no longer test positive for the virus itself. It is important to note that the science around COVID-19 antibody tests is evolving rapidly and there is still much uncertainty about what individual antibody test results mean for a single person and what population-level antibody test results mean for understanding the epidemiology of COVID-19 at a population level. These data only provide information on people tested. People receiving an antibody test do not reflect all people in New York City; therefore, these data may not reflect antibody prevalence among all New Yorkers. Increasing instances of screening programs further impact the generalizability of these data, as screening programs influence who and how many people are tested over time. Examples of screening programs in NYC include: employers screening their workers (e.g., hospitals), and long-term care facilities screening their residents. In addition, there may be potential biases toward people receiving an antibody test who have a positive result because people who were previously ill are preferentially seeking testing, in addition to the testing of persons with higher exposure (e.g., health care workers, first responders.) Rates were calculated using interpolated intercensal population estimates updated in 2019. These rates differ from previously reported rates based on the 2000 Census or previous versions of population estimates. The Health Department produced these population estimates based on estimates from the U.S. Census Bureau and NYC Department of City Planning. Antibody tests are categorized based on the date of specimen collection and are aggregated by full weeks starting each Sunday and ending on Saturday. For example, a person whose blood was collected for antibody testing on Wednesday, May 6 would be categorized as tested during the week ending May 9. A person tested twice in one week would only be counted once in that week. This dataset includes testing data beginning April 5, 2020. Data are updated daily, and the dataset preserves historical records and source data changes, so each extract date reflects the current copy of the data as of that date. For example, an extract date of 11/04/2020 and extract date of 11/03/2020 will both contain all records as they were as of that extract date. Without filtering or grouping by extract date, an analysis will almost certainly be miscalculating or counting the same values multiple times. To analyze the most current data, only use the latest extract date. Antibody tests that are missing dates are not included in the dataset; as dates are identified, these events are added. Lags between occurrence and report of cases and tests can be assessed by comparing counts and rates across multiple data extract dates. For further details, visit: • https://www1.nyc.gov/site/doh/covid/covid-19-data.page • https://github.com/nychealth/coronavirus-data
This dataset contains information on antibody testing for COVID-19: the number of people who received a test, the number of people with positive results, the percentage of people tested who tested positive, and the rate of testing per 100,000 people, stratified by week of testing. These data can also be accessed here: https://github.com/nychealth/coronavirus-data/blob/master/trends/antibody-by-week.csv Exposure to COVID-19 can be detected by measuring antibodies to the disease in a person’s blood, which can indicate that a person may have had an immune response to the virus. Antibodies are proteins produced by the body’s immune system that can be found in the blood. People can test positive for antibodies after they have been exposed, sometimes when they no longer test positive for the virus itself. It is important to note that the science around COVID-19 antibody tests is evolving rapidly and there is still much uncertainty about what individual antibody test results mean for a single person and what population-level antibody test results mean for understanding the epidemiology of COVID-19 at a population level. These data only provide information on people tested. People receiving an antibody test do not reflect all people in New York City; therefore, these data may not reflect antibody prevalence among all New Yorkers. Increasing instances of screening programs further impact the generalizability of these data, as screening programs influence who and how many people are tested over time. Examples of screening programs in NYC include: employers screening their workers (e.g., hospitals), and long-term care facilities screening their residents. In addition, there may be potential biases toward people receiving an antibody test who have a positive result because people who were previously ill are preferentially seeking testing, in addition to the testing of persons with higher exposure (e.g., health care workers, first responders.) Rates were calculated using interpolated intercensal population estimates updated in 2019. These rates differ from previously reported rates based on the 2000 Census or previous versions of population estimates. The Health Department produced these population estimates based on estimates from the U.S. Census Bureau and NYC Department of City Planning. Antibody tests are categorized based on the date of specimen collection and are aggregated by full weeks starting each Sunday and ending on Saturday. For example, a person whose blood was collected for antibody testing on Wednesday, May 6 would be categorized as tested during the week ending May 9. A person tested twice in one week would only be counted once in that week. This dataset includes testing data beginning April 5, 2020. Data are updated daily, and the dataset preserves historical records and source data changes, so each extract date reflects the current copy of the data as of that date. For example, an extract date of 11/04/2020 and extract date of 11/03/2020 will both contain all records as they were as of that extract date. Without filtering or grouping by extract date, an analysis will almost certainly be miscalculating or counting the same values multiple times. To analyze the most current data, only use the latest extract date. Antibody tests that are missing dates are not included in the dataset; as dates are identified, these events are added. Lags between occurrence and report of cases and tests can be assessed by comparing counts and rates across multiple data extract dates. For further details, visit: • https://www1.nyc.gov/site/doh/covid/covid-19-data.page • https://github.com/nychealth/coronavirus-data
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
The World Health Organization reported 6932591 Coronavirus Deaths since the epidemic began. In addition, countries reported 766440796 Coronavirus Cases. This dataset provides - World Coronavirus Deaths- actual values, historical data, forecast, chart, statistics, economic calendar and news.
Attribution-NonCommercial-ShareAlike 4.0 (CC BY-NC-SA 4.0)https://creativecommons.org/licenses/by-nc-sa/4.0/
License information was derived automatically
This is a daily updated dataset of COVID-19 deaths around the world. The dataset contains data of 45 countries. This data was collected from
us-counties.csv
contains data of the daily number of new cases and deaths, the seven-day rolling average and the seven-day rolling average per 100,000 residents of US at county level. The average reported is the seven day trailing average i.e. average of the day reported and six days prior.
all_weekly_excess_deaths.csv
collates detailed weekly breakdowns from official sources around the world.
Image credits: Unsplash - schluditsch
Let's pray for the ones who lost their lives fighting the battle and for the ones who risk their lives against this virus 🙏
https://www.usa.gov/government-workshttps://www.usa.gov/government-works
After May 3, 2024, this dataset and webpage will no longer be updated because hospitals are no longer required to report data on COVID-19 hospital admissions, and hospital capacity and occupancy data, to HHS through CDC’s National Healthcare Safety Network. Data voluntarily reported to NHSN after May 1, 2024, will be available starting May 10, 2024, at COVID Data Tracker Hospitalizations.
The following dataset provides facility-level data for hospital utilization aggregated on a weekly basis (Sunday to Saturday). These are derived from reports with facility-level granularity across two main sources: (1) HHS TeleTracking, and (2) reporting provided directly to HHS Protect by state/territorial health departments on behalf of their healthcare facilities.
The hospital population includes all hospitals registered with Centers for Medicare & Medicaid Services (CMS) as of June 1, 2020. It includes non-CMS hospitals that have reported since July 15, 2020. It does not include psychiatric, rehabilitation, Indian Health Service (IHS) facilities, U.S. Department of Veterans Affairs (VA) facilities, Defense Health Agency (DHA) facilities, and religious non-medical facilities.
For a given entry, the term “collection_week” signifies the start of the period that is aggregated. For example, a “collection_week” of 2020-11-15 means the average/sum/coverage of the elements captured from that given facility starting and including Sunday, November 15, 2020, and ending and including reports for Saturday, November 21, 2020.
Reported elements include an append of either “_coverage”, “_sum”, or “_avg”.
The file will be updated weekly. No statistical analysis is applied to impute non-response. For averages, calculations are based on the number of values collected for a given hospital in that collection week. Suppression is applied to the file for sums and averages less than four (4). In these cases, the field will be replaced with “-999,999”.
A story page was created to display both corrected and raw datasets and can be accessed at this link: https://healthdata.gov/stories/s/nhgk-5gpv
This data is preliminary and subject to change as more data become available. Data is available starting on July 31, 2020.
Sometimes, reports for a given facility will be provided to both HHS TeleTracking and HHS Protect. When this occurs, to ensure that there are not duplicate reports, deduplication is applied according to prioritization rules within HHS Protect.
For influenza fields listed in the file, the current HHS guidance marks these fields as optional. As a result, coverage of these elements are varied.
For recent updates to the dataset, scroll to the bottom of the dataset description.
On May 3, 2021, the following fields have been added to this data set.
On May 8, 2021, this data set has been converted to a corrected data set. The corrections applied to this data set are to smooth out data anomalies caused by keyed in data errors. To help determine which records have had corrections made to it. An additional Boolean field called is_corrected has been added.
On May 13, 2021 Changed vaccination fields from sum to max or min fields. This reflects the maximum or minimum number reported for that metric in a given week.
On June 7, 2021 Changed vaccination fields from max or min fields to Wednesday reported only. This reflects that the number reported for that metric is only reported on Wednesdays in a given week.
On September 20, 2021, the following has been updated: The use of analytic dataset as a source.
On January 19, 2022, the following fields have been added to this dataset:
On April 28, 2022, the following pediatric fields have been added to this dataset:
On October 24, 2022, the data includes more analytical calculations in efforts to provide a cleaner dataset. For a raw version of this dataset, please follow this link: https://healthdata.gov/Hospital/COVID-19-Reported-Patient-Impact-and-Hospital-Capa/uqq2-txqb
Due to changes in reporting requirements, after June 19, 2023, a collection week is defined as starting on a Sunday and ending on the next Saturday.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Introduction
There are several works based on Natural Language Processing on newspaper reports. Mining opinions from headlines [ 1 ] using Standford NLP and SVM by Rameshbhaiet. Al.compared several algorithms on a small and large dataset. Rubinet. al., in their paper [ 2 ], created a mechanism to differentiate fake news from real ones by building a set of characteristics of news according to their types. The purpose was to contribute to the low resource data available for training machine learning algorithms. Doumitet. al.in [ 3 ] have implemented LDA, a topic modeling approach to study bias present in online news media.
However, there are not many NLP research invested in studying COVID-19. Most applications include classification of chest X-rays and CT-scans to detect presence of pneumonia in lungs [ 4 ], a consequence of the virus. Other research areas include studying the genome sequence of the virus[ 5 ][ 6 ][ 7 ] and replicating its structure to fight and find a vaccine. This research is crucial in battling the pandemic. The few NLP based research publications are sentiment classification of online tweets by Samuel et el [ 8 ] to understand fear persisting in people due to the virus. Similar work has been done using the LSTM network to classify sentiments from online discussion forums by Jelodaret. al.[ 9 ]. NKK dataset is the first study on a comparatively larger dataset of a newspaper report on COVID-19, which contributed to the virus’s awareness to the best of our knowledge.
2 Data-set Introduction
2.1 Data Collection
We accumulated 1000 online newspaper report from United States of America (USA) on COVID-19. The newspaper includes The Washington Post (USA) and StarTribune (USA). We have named it as “Covid-News-USA-NNK”. We also accumulated 50 online newspaper report from Bangladesh on the issue and named it “Covid-News-BD-NNK”. The newspaper includes The Daily Star (BD) and Prothom Alo (BD). All these newspapers are from the top provider and top read in the respective countries. The collection was done manually by 10 human data-collectors of age group 23- with university degrees. This approach was suitable compared to automation to ensure the news were highly relevant to the subject. The newspaper online sites had dynamic content with advertisements in no particular order. Therefore there were high chances of online scrappers to collect inaccurate news reports. One of the challenges while collecting the data is the requirement of subscription. Each newspaper required $1 per subscriptions. Some criteria in collecting the news reports provided as guideline to the human data-collectors were as follows:
The headline must have one or more words directly or indirectly related to COVID-19.
The content of each news must have 5 or more keywords directly or indirectly related to COVID-19.
The genre of the news can be anything as long as it is relevant to the topic. Political, social, economical genres are to be more prioritized.
Avoid taking duplicate reports.
Maintain a time frame for the above mentioned newspapers.
To collect these data we used a google form for USA and BD. We have two human editor to go through each entry to check any spam or troll entry.
2.2 Data Pre-processing and Statistics
Some pre-processing steps performed on the newspaper report dataset are as follows:
Remove hyperlinks.
Remove non-English alphanumeric characters.
Remove stop words.
Lemmatize text.
While more pre-processing could have been applied, we tried to keep the data as much unchanged as possible since changing sentence structures could result us in valuable information loss. While this was done with help of a script, we also assigned same human collectors to cross check for any presence of the above mentioned criteria.
The primary data statistics of the two dataset are shown in Table 1 and 2.
Table 1: Covid-News-USA-NNK data statistics
No of words per headline
7 to 20
No of words per body content
150 to 2100
Table 2: Covid-News-BD-NNK data statistics No of words per headline
10 to 20
No of words per body content
100 to 1500
2.3 Dataset Repository
We used GitHub as our primary data repository in account name NKK^1. Here, we created two repositories USA-NKK^2 and BD-NNK^3. The dataset is available in both CSV and JSON format. We are regularly updating the CSV files and regenerating JSON using a py script. We provided a python script file for essential operation. We welcome all outside collaboration to enrich the dataset.
3 Literature Review
Natural Language Processing (NLP) deals with text (also known as categorical) data in computer science, utilizing numerous diverse methods like one-hot encoding, word embedding, etc., that transform text to machine language, which can be fed to multiple machine learning and deep learning algorithms.
Some well-known applications of NLP includes fraud detection on online media sites[ 10 ], using authorship attribution in fallback authentication systems[ 11 ], intelligent conversational agents or chatbots[ 12 ] and machine translations used by Google Translate[ 13 ]. While these are all downstream tasks, several exciting developments have been made in the algorithm solely for Natural Language Processing tasks. The two most trending ones are BERT[ 14 ], which uses bidirectional encoder-decoder architecture to create the transformer model, that can do near-perfect classification tasks and next-word predictions for next generations, and GPT-3 models released by OpenAI[ 15 ] that can generate texts almost human-like. However, these are all pre-trained models since they carry huge computation cost. Information Extraction is a generalized concept of retrieving information from a dataset. Information extraction from an image could be retrieving vital feature spaces or targeted portions of an image; information extraction from speech could be retrieving information about names, places, etc[ 16 ]. Information extraction in texts could be identifying named entities and locations or essential data. Topic modeling is a sub-task of NLP and also a process of information extraction. It clusters words and phrases of the same context together into groups. Topic modeling is an unsupervised learning method that gives us a brief idea about a set of text. One commonly used topic modeling is Latent Dirichlet Allocation or LDA[17].
Keyword extraction is a process of information extraction and sub-task of NLP to extract essential words and phrases from a text. TextRank [ 18 ] is an efficient keyword extraction technique that uses graphs to calculate the weight of each word and pick the words with more weight to it.
Word clouds are a great visualization technique to understand the overall ’talk of the topic’. The clustered words give us a quick understanding of the content.
4 Our experiments and Result analysis
We used the wordcloud library^4 to create the word clouds. Figure 1 and 3 presents the word cloud of Covid-News-USA- NNK dataset by month from February to May. From the figures 1,2,3, we can point few information:
In February, both the news paper have talked about China and source of the outbreak.
StarTribune emphasized on Minnesota as the most concerned state. In April, it seemed to have been concerned more.
Both the newspaper talked about the virus impacting the economy, i.e, bank, elections, administrations, markets.
Washington Post discussed global issues more than StarTribune.
StarTribune in February mentioned the first precautionary measurement: wearing masks, and the uncontrollable spread of the virus throughout the nation.
While both the newspaper mentioned the outbreak in China in February, the weight of the spread in the United States are more highlighted through out March till May, displaying the critical impact caused by the virus.
We used a script to extract all numbers related to certain keywords like ’Deaths’, ’Infected’, ’Died’ , ’Infections’, ’Quarantined’, Lock-down’, ’Diagnosed’ etc from the news reports and created a number of cases for both the newspaper. Figure 4 shows the statistics of this series. From this extraction technique, we can observe that April was the peak month for the covid cases as it gradually rose from February. Both the newspaper clearly shows us that the rise in covid cases from February to March was slower than the rise from March to April. This is an important indicator of possible recklessness in preparations to battle the virus. However, the steep fall from April to May also shows the positive response against the attack. We used Vader Sentiment Analysis to extract sentiment of the headlines and the body. On average, the sentiments were from -0.5 to -0.9. Vader Sentiment scale ranges from -1(highly negative to 1(highly positive). There were some cases
where the sentiment scores of the headline and body contradicted each other,i.e., the sentiment of the headline was negative but the sentiment of the body was slightly positive. Overall, sentiment analysis can assist us sort the most concerning (most negative) news from the positive ones, from which we can learn more about the indicators related to COVID-19 and the serious impact caused by it. Moreover, sentiment analysis can also provide us information about how a state or country is reacting to the pandemic. We used PageRank algorithm to extract keywords from headlines as well as the body content. PageRank efficiently highlights important relevant keywords in the text. Some frequently occurring important keywords extracted from both the datasets are: ’China’, Government’, ’Masks’, ’Economy’, ’Crisis’, ’Theft’ , ’Stock market’ , ’Jobs’ , ’Election’, ’Missteps’, ’Health’, ’Response’. Keywords extraction acts as a filter allowing quick searches for indicators in case of locating situations of the economy,
Note: After May 3, 2024, this dataset will no longer be updated because hospitals are no longer required to report data on COVID-19 hospital admissions, hospital capacity, or occupancy data to HHS through CDC’s National Healthcare Safety Network (NHSN). The related CDC COVID Data Tracker site was revised or retired on May 10, 2023.
Note: May 3,2024: Due to incomplete or missing hospital data received for the April 21,2024 through April 27, 2024 reporting period, the COVID-19 Hospital Admissions Level could not be calculated for CNMI and will be reported as “NA” or “Not Available” in the COVID-19 Hospital Admissions Level data released on May 3, 2024.
This dataset represents COVID-19 hospitalization data and metrics aggregated to county or county-equivalent, for all counties or county-equivalents (including territories) in the United States. COVID-19 hospitalization data are reported to CDC’s National Healthcare Safety Network, which monitors national and local trends in healthcare system stress, capacity, and community disease levels for approximately 6,000 hospitals in the United States. Data reported by hospitals to NHSN and included in this dataset represent aggregated counts and include metrics capturing information specific to COVID-19 hospital admissions, and inpatient and ICU bed capacity occupancy.
Reporting information:
Note: DPH is updating and streamlining the COVID-19 cases, deaths, and testing data. As of 6/27/2022, the data will be published in four tables instead of twelve.
The COVID-19 Cases, Deaths, and Tests by Day dataset contains cases and test data by date of sample submission. The death data are by date of death. This dataset is updated daily and contains information back to the beginning of the pandemic. The data can be found at https://data.ct.gov/Health-and-Human-Services/COVID-19-Cases-Deaths-and-Tests-by-Day/g9vi-2ahj.
The COVID-19 State Metrics dataset contains over 93 columns of data. This dataset is updated daily and currently contains information starting June 21, 2022 to the present. The data can be found at https://data.ct.gov/Health-and-Human-Services/COVID-19-State-Level-Data/qmgw-5kp6 .
The COVID-19 County Metrics dataset contains 25 columns of data. This dataset is updated daily and currently contains information starting June 16, 2022 to the present. The data can be found at https://data.ct.gov/Health-and-Human-Services/COVID-19-County-Level-Data/ujiq-dy22 .
The COVID-19 Town Metrics dataset contains 16 columns of data. This dataset is updated daily and currently contains information starting June 16, 2022 to the present. The data can be found at https://data.ct.gov/Health-and-Human-Services/COVID-19-Town-Level-Data/icxw-cada . To protect confidentiality, if a town has fewer than 5 cases or positive NAAT tests over the past 7 days, those data will be suppressed.
Count of COVID-19-associated deaths by date of death. Deaths reported to either the OCME or DPH are included in the COVID-19 data. COVID-19-associated deaths include persons who tested positive for COVID-19 around the time of death and persons who were not tested for COVID-19 whose death certificate lists COVID-19 disease as a cause of death or a significant condition contributing to death.
Data on Connecticut deaths were obtained from the Connecticut Deaths Registry maintained by the DPH Office of Vital Records. Cause of death was determined by a death certifier (e.g., physician, APRN, medical examiner) using their best clinical judgment. Additionally, all COVID-19 deaths, including suspected or related, are required to be reported to OCME. On April 4, 2020, CT DPH and OCME released a joint memo to providers and facilities within Connecticut providing guidelines for certifying deaths due to COVID-19 that were consistent with the CDC’s guidelines and a reminder of the required reporting to OCME.25,26 As of July 1, 2021, OCME had reviewed every case reported and performed additional investigation on about one-third of reported deaths to better ascertain if COVID-19 did or did not cause or contribute to the death. Some of these investigations resulted in the OCME performing postmortem swabs for PCR testing on individuals whose deaths were suspected to be due to COVID-19, but antemortem diagnosis was unable to be made.31 The OCME issued or re-issued about 10% of COVID-19 death certificates and, when appropriate, removed COVID-19 from the death certificate. For standardization and tabulation of mortality statistics, written cause of death statements made by the certifiers on death certificates are sent to the National Center for Health Statistics (NCHS) at the CDC which assigns cause of death codes according to the International Causes of Disease 10th Revision (ICD-10) classification system.25,26 COVID-19 deaths in this report are defined as those for which the death certificate has an ICD-10 code of U07.1 as either a primary (underlying) or a contributing cause of death. More information on COVID-19 mortality can be found at the following link: https://portal.ct.gov/DPH/Health-Information-Systems--Reporting/Mortality/Mortality-Statistics
Note the counts in this dataset may vary from the death counts in the other COVID-19-related datasets published on data.ct.gov, where deaths are counted on the date reported rather than the date of death
Note: The cumulative case count for some counties (with small population) is higher than expected due to the inclusion of non-permanent residents in COVID-19 case counts.
Reporting of Aggregate Case and Death Count data was discontinued on May 11, 2023, with the expiration of the COVID-19 public health emergency declaration. Although these data will continue to be publicly available, this dataset will no longer be updated.
Aggregate Data Collection Process Since the beginning of the COVID-19 pandemic, data were reported through a robust process with the following steps:
This process was collaborative, with CDC and jurisdictions working together to ensure the accuracy of COVID-19 case and death numbers. County counts provided the most up-to-date numbers on cases and deaths by report date. Throughout data collection, CDC retrospectively updated counts to correct known data quality issues. CDC also worked with jurisdictions after the end of the public health emergency declaration to finalize county data.
Important note: The counts reflected during a given time period in this dataset may not match the counts reflected for the same time period in the daily archived dataset noted above. Discrepancies may exist due to differences between county and state COVID-19 case surveillance and reconciliation efforts.
The surveillance case definition for COVID-19, a nationally notifiable disease, was first described in a position statement from the Council for State and Territorial Epidemiologists, which was later revised. However, there is some variation in how jurisdictions implement these case classifications. More information on how CDC collects COVID-19 case surveillance data can be found at FAQ: COVID-19 Data and Surveillance.
Confirmed and Probable Counts In this dataset, counts by jurisdiction are not displayed by confirmed or probable status. Instead, counts of confirmed and probable cases and deaths are included in the Total Cases and Total Deaths columns, when available. Not all jurisdictions reported probable cases and deaths to CDC. Confirmed and probable case definition criteria are described here: "https://ndc.services.cdc.gov/case-definitions/coronavirus-disease-2019-covid-19/">Coronavirus Disease 2019 (COVID-19) 2023 Case Definition | CDC Council of State and Territorial Epidemiologists (ymaws.com).
Deaths COVID-19 deaths were reported to CDC from several sources since the beginning of the pandemic including aggregate death data and NCHS Provisional Death Counts. Historic information presented on the COVID Data Tracker pages were based on the same source (Aggregate Data) as the present dataset until the expiration of the public health emergency declaration on May 11, 2023; however, the NCHS Death Counts are based on death certificate data that use information reported by physicians, medical examiners, or coroners in the cause-of-death section of each certificate. Counts from previous weeks were continually revised as more records were received and processed.
Number of Jurisdictions Reporting There were 60 public health jurisdictions that reported cases and deaths of COVID-19. This included the 50 states, the District of Columbia, New York City, the U.S. territories of American Samoa, Guam, the Commonwealth of the Northern Mariana Islands, Puerto Rico, and the U.S Virgin Islands as well as three independent countries in compacts of free association with the United States, Federated States of Micronesia, Republic of the Marshall Islands, and Republic of Palau. In total there were 3,222 counties for which counts were tracked within the 60 public health jurisdictions.
Additional COVID-19 public use datasets, include line-level (patient-level) data, are available at: https://data.cdc.gov/browse?tags=covid-19.
Note: In early 2020, Alaska enacted changes to their counties/boroughs due to low populations in certain areas:
Case and death counts for Yakutat City and Borough, Alaska, are shown as 0 by default. Case and death counts for Hoonah-Angoon Census Area, Alaska, represent total cases and deaths in residents of Hoonah-Angoon Census Area, Alaska, and Yakutat City and Borough, Alaska. Case and death counts for Bristol Bay Borough, Alaska, are shown as 0 by default. Case and death counts for Lake and Peninsula Borough, Alaska, represent total cases and deaths in residents of Lake and Peninsula Borough, Alaska, and Bristol Bay Borough, Alaska.
Historical cases and deaths are not tracked separately in the county level datasets, and differences in weekly new cases and deaths could exist when county-level data are aggregated to the state-level (i.e., when compared to this dataset: https://data.cdc.gov/Case-Surveillance/United-States-COVID-19-Cases-and-Deaths-by-State-o/9mfq-cb36).
https://www.usa.gov/government-workshttps://www.usa.gov/government-works
After over two years of public reporting, the Community Profile Report will no longer be produced and distributed after February 2023. The final release will be on February 23, 2023. We want to thank everyone who contributed to the design, production, and review of this report and we hope that it provided insight into the data trends throughout the COVID-19 pandemic. Data about COVID-19 will continue to be updated at CDC’s COVID Data Tracker.
The Community Profile Report (CPR) is generated by the Data Strategy and Execution Workgroup in the Joint Coordination Cell, under the White House COVID-19 Team. It is managed by an interagency team with representatives from multiple agencies and offices (including the United States Department of Health and Human Services, the Centers for Disease Control and Prevention, the Assistant Secretary for Preparedness and Response, and the Indian Health Service). The CPR provides easily interpretable information on key indicators for all regions, states, core-based statistical areas (CBSAs), and counties across the United States. It is a snapshot in time that:
Data in this report may differ from data on state and local websites. This may be due to differences in how data were reported (e.g., date specimen obtained, or date reported for cases) or how the metrics are calculated. Historical data may be updated over time due to delayed reporting. Data presented here use standard metrics across all geographic levels in the United States. It facilitates the understanding of COVID-19 pandemic trends across the United States by using standardized data. The footnotes describe each data source and the methods used for calculating the metrics. For additional data for any particular locality, visit the relevant health department website. Additional data and features are forthcoming.
*Color thresholds for each category are defined on the color thresholds tab
Effective April 30, 2021, the Community Profile Report will be distributed on Monday through Friday. There will be no impact to the data represented in these reports due to this change.
Effective June 22, 2021, the Community Profile Report will only be updated twice a week, on Tuesdays and Fridays.
Effective August 2, 2021, the Community Profile Report will return to being updated Monday through Friday.
Effective June 22, 2022, the Community Profile Report will only be updated twice a week, on Wednesdays and Fridays.
Data for CDC’s COVID Data Tracker site on Rates of COVID-19 Cases and Deaths by Vaccination Status. Click 'More' for important dataset description and footnotes
Dataset and data visualization details: These data were posted on October 21, 2022, archived on November 18, 2022, and revised on February 22, 2023. These data reflect cases among persons with a positive specimen collection date through September 24, 2022, and deaths among persons with a positive specimen collection date through September 3, 2022.
Vaccination status: A person vaccinated with a primary series had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after verifiably completing the primary series of an FDA-authorized or approved COVID-19 vaccine. An unvaccinated person had SARS-CoV-2 RNA or antigen detected on a respiratory specimen and has not been verified to have received COVID-19 vaccine. Excluded were partially vaccinated people who received at least one FDA-authorized vaccine dose but did not complete a primary series ≥14 days before collection of a specimen where SARS-CoV-2 RNA or antigen was detected. Additional or booster dose: A person vaccinated with a primary series and an additional or booster dose had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after receipt of an additional or booster dose of any COVID-19 vaccine on or after August 13, 2021. For people ages 18 years and older, data are graphed starting the week including September 24, 2021, when a COVID-19 booster dose was first recommended by CDC for adults 65+ years old and people in certain populations and high risk occupational and institutional settings. For people ages 12-17 years, data are graphed starting the week of December 26, 2021, 2 weeks after the first recommendation for a booster dose for adolescents ages 16-17 years. For people ages 5-11 years, data are included starting the week of June 5, 2022, 2 weeks after the first recommendation for a booster dose for children aged 5-11 years. For people ages 50 years and older, data on second booster doses are graphed starting the week including March 29, 2022, when the recommendation was made for second boosters. Vertical lines represent dates when changes occurred in U.S. policy for COVID-19 vaccination (details provided above). Reporting is by primary series vaccine type rather than additional or booster dose vaccine type. The booster dose vaccine type may be different than the primary series vaccine type. ** Because data on the immune status of cases and associated deaths are unavailable, an additional dose in an immunocompromised person cannot be distinguished from a booster dose. This is a relevant consideration because vaccines can be less effective in this group. Deaths: A COVID-19–associated death occurred in a person with a documented COVID-19 diagnosis who died; health department staff reviewed to make a determination using vital records, public health investigation, or other data sources. Rates of COVID-19 deaths by vaccination status are reported based on when the patient was tested for COVID-19, not the date they died. Deaths usually occur up to 30 days after COVID-19 diagnosis. Participating jurisdictions: Currently, these 31 health departments that regularly link their case surveillance to immunization information system data are included in these incidence rate estimates: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Idaho, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Michigan, Minnesota, Nebraska, New Jersey, New Mexico, New York, New York City (New York), North Carolina, Philadelphia (Pennsylvania), Rhode Island, South Dakota, Tennessee, Texas, Utah, Washington, and West Virginia; 30 jurisdictions also report deaths among vaccinated and unvaccinated people. These jurisdictions represent 72% of the total U.S. population and all ten of the Health and Human Services Regions. Data on cases among people who received additional or booster doses were reported from 31 jurisdictions; 30 jurisdictions also reported data on deaths among people who received one or more additional or booster dose; 28 jurisdictions reported cases among people who received two or more additional or booster doses; and 26 jurisdictions reported deaths among people who received two or more additional or booster doses. This list will be updated as more jurisdictions participate. Incidence rate estimates: Weekly age-specific incidence rates by vaccination status were calculated as the number of cases or deaths divided by the number of people vaccinated with a primary series, overall or with/without a booster dose (cumulative) or unvaccinated (obtained by subtracting the cumulative number of people vaccinated with a primary series and partially vaccinated people from the 2019 U.S. intercensal population estimates) and multiplied by 100,000. Overall incidence rates were age-standardized using the 2000 U.S. Census standard population. To estimate population counts for ages 6 months through 1 year, half of the single-year population counts for ages 0 through 1 year were used. All rates are plotted by positive specimen collection date to reflect when incident infections occurred. For the primary series analysis, age-standardized rates include ages 12 years and older from April 4, 2021 through December 4, 2021, ages 5 years and older from December 5, 2021 through July 30, 2022 and ages 6 months and older from July 31, 2022 onwards. For the booster dose analysis, age-standardized rates include ages 18 years and older from September 19, 2021 through December 25, 2021, ages 12 years and older from December 26, 2021, and ages 5 years and older from June 5, 2022 onwards. Small numbers could contribute to less precision when calculating death rates among some groups. Continuity correction: A continuity correction has been applied to the denominators by capping the percent population coverage at 95%. To do this, we assumed that at least 5% of each age group would always be unvaccinated in each jurisdiction. Adding this correction ensures that there is always a reasonable denominator for the unvaccinated population that would prevent incidence and death rates from growing unrealistically large due to potential overestimates of vaccination coverage. Incidence rate ratios (IRRs): IRRs for the past one month were calculated by dividing the average weekly incidence rates among unvaccinated people by that among people vaccinated with a primary series either overall or with a booster dose. Publications: Scobie HM, Johnson AG, Suthar AB, et al. Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status — 13 U.S. Jurisdictions, April 4–July 17, 2021. MMWR Morb Mortal Wkly Rep 2021;70:1284–1290. Johnson AG, Amin AB, Ali AR, et al. COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence — 25 U.S. Jurisdictions, April 4–December 25, 2021. MMWR Morb Mortal Wkly Rep 2022;71:132–138
This dataset contains information on antibody testing for COVID-19: the number of people who received a test, the number of people with positive results, the percentage of people tested who tested positive, and the rate of testing per 100,000 people, stratified by modified ZIP Code Tabulation Area (ZCTA) of residence. Modified ZCTA reflects the first non-missing address within NYC for each person reported with an antibody test result. This unit of geography is similar to ZIP codes but combines census blocks with smaller populations to allow more stable estimates of population size for rate calculation. It can be challenging to map data that are reported by ZIP Code. A ZIP Code doesn’t refer to an area, but rather a collection of points that make up a mail delivery route. Furthermore, there are some buildings that have their own ZIP Code, and some non-residential areas with ZIP Codes. To deal with the challenges of ZIP Codes, the Health Department uses ZCTAs which solidify ZIP codes into units of area. Often, data reported by ZIP code are actually mapped by ZCTA. The ZCTA geography was developed by the U.S. Census Bureau. These data can also be accessed here: https://github.com/nychealth/coronavirus-data/blob/master/totals/antibody-by-modzcta.csv Exposure to COVID-19 can be detected by measuring antibodies to the disease in a person’s blood, which can indicate that a person may have had an immune response to the virus. Antibodies are proteins produced by the body’s immune system that can be found in the blood. People can test positive for antibodies after they have been exposed, sometimes when they no longer test positive for the virus itself. It is important to note that the science around COVID-19 antibody tests is evolving rapidly and there is still much uncertainty about what individual antibody test results mean for a single person and what population-level antibody test results mean for understanding the epidemiology of COVID-19 at a population level. These data only provide information on people tested. People receiving an antibody test do not reflect all people in New York City; therefore, these data may not reflect antibody prevalence among all New Yorkers. Increasing instances of screening programs further impact the generalizability of these data, as screening programs influence who and how many people are tested over time. Examples of screening programs in NYC include: employers screening their workers (e.g., hospitals), and long-term care facilities screening their residents. In addition, there may be potential biases toward people receiving an antibody test who have a positive result because people who were previously ill are preferentially seeking testing, in addition to the testing of persons with higher exposure (e.g., health care workers, first responders) Rates were calculated using interpolated intercensal population estimates updated in 2019. These rates differ from previously reported rates based on the 2000 Census or previous versions of population estimates. The Health Department produced these population estimates based on estimates from the U.S. Census Bureau and NYC Department of City Planning. Antibody tests are categorized based on the date of specimen collection and are aggregated by full weeks starting each Sunday and ending on Saturday. For example, a person whose blood was collected for antibody testing on Wednesday, May 6 would be categorized as tested during the week ending May 9. A person tested twice in one week would only be counted once in that week. This dataset includes testing data beginning April 5, 2020. Data are updated daily, and the dataset preserves historical records and source data changes, so each extract date reflects the current copy of the data as of that date. For example, an extract date of 11/04/2020 and extract date of 11/03/2020 will both contain all records as they were as of that extract date. Without filtering or grouping by extract date, an analysis wi
Daily count of NYC residents who tested positive for SARS-CoV-2, who were hospitalized with COVID-19, and deaths among COVID-19 patients.
Note that this dataset currently pulls from https://raw.githubusercontent.com/nychealth/coronavirus-data/master/trends/data-by-day.csv on a daily basis.
Reporting of new Aggregate Case and Death Count data was discontinued May 11, 2023, with the expiration of the COVID-19 public health emergency declaration. This dataset will receive a final update on June 1, 2023, to reconcile historical data through May 10, 2023, and will remain publicly available.
Aggregate Data Collection Process Since the start of the COVID-19 pandemic, data have been gathered through a robust process with the following steps:
Methodology Changes Several differences exist between the current, weekly-updated dataset and the archived version:
Confirmed and Probable Counts In this dataset, counts by jurisdiction are not displayed by confirmed or probable status. Instead, confirmed and probable cases and deaths are included in the Total Cases and Total Deaths columns, when available. Not all jurisdictions report probable cases and deaths to CDC.* Confirmed and probable case definition criteria are described here:
Council of State and Territorial Epidemiologists (ymaws.com).
Deaths CDC reports death data on other sections of the website: CDC COVID Data Tracker: Home, CDC COVID Data Tracker: Cases, Deaths, and Testing, and NCHS Provisional Death Counts. Information presented on the COVID Data Tracker pages is based on the same source (to